Get the Stockscreener App
3.90
4.00%
0.15
Collplant Biotechnologies Ltd Stock (CLGN) Forecast
The Collplant Biotechnologies Ltd (CLGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.8599, representing a +152.82% increase from the current price of $3.90. The highest analyst price target is $15.26, and the lowest is $4.4603.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLGN Price Target
Average 55.39
(+1,320% Upside)
Is Collplant Biotechnologies Ltd (CLGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.65 | Neutral |
| STOCH(9,6) | 44.28 | Neutral |
| STOCHRSI(14) | 64.31 | Neutral |
| MACD(12,26) | 0.0251 | Sell |
| ADX(14) | 33.83 | Buy |
| William %R | -48.25 | Neutral |
| CCI(14) | 43.16 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.757
Buy
|
3.7568
Buy
|
| MA20 |
3.7025
Buy
|
3.7436
Buy
|
| MA50 |
3.6303
Buy
|
3.6788
Buy
|
| MA100 |
3.4965
Buy
|
4.088
Sell
|
| MA200 |
5.2877
Sell
|
7.0245
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, CLGN could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CLGN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.65 indicates that CLGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.28 indicates that CLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.31 indicates that CLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.83 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 43.16 indicates that CLGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CLGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Collplant Biotechnologies Ltd financial reports and earnings history, Collplant Biotechnologies Ltd (CLGN) stock could reach $48.20 by 2030, $368.55 by 2040 and $881.13 by 2050. See the projected annual prices until 2050 of the Collplant Biotechnologies Ltd stock below:
- Collplant Biotechnologies Ltd (CLGN) is expected to reach an average price of $186.09 in 2035, with a high prediction of $186.09 and a low estimate of $188.21. This indicates an $4,671% rise from the last recorded price of $3.90.
- Collplant Biotechnologies Ltd (CLGN) stock is projected to chart a bullish course in 2040, with an average price target of $355.31, representing an $9,011% surge from its current level. The forecast ranges from a conservative $360.61 to a sky-high $368.55.
- Our analysts predict Collplant Biotechnologies Ltd (CLGN) to jump 16,213% by 2045, soaring from $631.96 to an average price of $636.22, potentially reaching $631.24. While $631.96 is the low estimate, the potential upside is significant.
- Collplant Biotechnologies Ltd (CLGN) stock is expected to climb by 2050, reaching an average of $887.63, a $22,660% jump from its current level. However, a wide range of estimates exists, with high and low targets of $881.13 and $883.02, respectively, highlighting the market's uncertainty.
Collplant Biotechnologies Ltd Stock (CLGN) Year by Year Forecast
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2026
The predicted value for Collplant Biotechnologies Ltd (CLGN) in 2026 is set at an average of $25.79. Estimates vary from a peak of $48.94 to a trough of $2.637, indicating an +561.26% surge from the present price of $3.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $34.02 | $4.4603 | $15.26 | +772.33% |
| December, 2026 | $83.24 | $43.30 | $48.94 | +2,034% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Collplant Biotechnologies Ltd (CLGN) is $83.63, with a high forecast of $110.11 and a low forecast of $57.14. This indicates an +2,044% increase from the last price of $3.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $91.16 | $57.14 | $69.86 | +2,237% |
| February, 2027 | $107.63 | $106.14 | $106.33 | +2,660% |
| March, 2027 | $104.48 | $99.20 | $95.66 | +2,579% |
| April, 2027 | $86.70 | $87.40 | $102.36 | +2,123% |
| May, 2027 | $95.81 | $91.11 | $97.03 | +2,357% |
| June, 2027 | $97.33 | $104.03 | $100.17 | +2,396% |
| July, 2027 | $106.05 | $101.99 | $103.55 | +2,619% |
| August, 2027 | $99.45 | $104.35 | $100.54 | +2,450% |
| September, 2027 | $84.37 | $99.27 | $106.01 | +2,063% |
| October, 2027 | $101.54 | $92.35 | $99.41 | +2,504% |
| November, 2027 | $110.09 | $100.75 | $106.49 | +2,723% |
| December, 2027 | $111.11 | $108.25 | $110.11 | +2,749% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2028
In 2028, Collplant Biotechnologies Ltd (CLGN) is projected to reach an average price of $81.50, with a high projection of $116.54 and a low estimate of $46.46. This indicates an +1,990% rise from the last price of $3.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $119.77 | $112.99 | $116.54 | +2,971% |
| February, 2028 | $83.83 | $87.93 | $102.79 | +2,050% |
| March, 2028 | $63.85 | $84.60 | $74.77 | +1,537% |
| April, 2028 | $41.57 | $46.46 | $37.79 | +965.98% |
| May, 2028 | $68.37 | $48.53 | $50.89 | +1,653% |
| June, 2028 | $83.99 | $77.83 | $78.50 | +2,054% |
| July, 2028 | $81.55 | $83.45 | $82.12 | +1,991% |
| August, 2028 | $74.82 | $75.52 | $78.73 | +1,818% |
| September, 2028 | $64.04 | $69.34 | $71.50 | +1,542% |
| October, 2028 | $79.34 | $67.82 | $79.65 | +1,934% |
| November, 2028 | $68.76 | $77.26 | $74.92 | +1,663% |
| December, 2028 | $67.78 | $69.58 | $68.82 | +1,638% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2029
The 2029 price forecast for Collplant Biotechnologies Ltd Stock (CLGN) is $63.68 on average, with a high prediction of $78.88 and a low estimate of $48.49. This represents an +1,533% increase from the previous price of $3.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $81.28 | $77.20 | $78.88 | +1,984% |
| February, 2029 | $73.60 | $75.50 | $78.16 | +1,787% |
| March, 2029 | $73.42 | $74.72 | $73.42 | +1,783% |
| April, 2029 | $61.82 | $65.72 | $72.48 | +1,485% |
| May, 2029 | $65.64 | $65.60 | $65.64 | +1,583% |
| June, 2029 | $60.76 | $64.56 | $61.70 | +1,458% |
| July, 2029 | $62.96 | $63.86 | $62.20 | +1,514% |
| August, 2029 | $59.09 | $60.09 | $58.81 | +1,415% |
| September, 2029 | $41.93 | $49.71 | $51.47 | +975.03% |
| October, 2029 | $53.31 | $48.49 | $51.31 | +1,267% |
| November, 2029 | $51.73 | $53.35 | $51.39 | +1,226% |
| December, 2029 | $53.33 | $53.30 | $51.45 | +1,267% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2030
Collplant Biotechnologies Ltd Stock (CLGN) is expected to reach an average price of $44.36 in 2030, with a high forecast of $50.57 and a low forecast of $38.15. This signifies an +1,037% surge from the last price of $3.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.05 | $45.37 | $48.20 | +1,029% |
| February, 2030 | $42.72 | $43.37 | $43.81 | +995.38% |
| March, 2030 | $49.77 | $46.28 | $46.86 | +1,176% |
| April, 2030 | $44.49 | $49.21 | $50.57 | +1,041% |
| May, 2030 | $48.91 | $45.90 | $44.91 | +1,154% |
| June, 2030 | $38.15 | $38.15 | $45.21 | +878.20% |
| July, 2030 | $40.53 | $40.77 | $38.03 | +939.32% |
| August, 2030 | $40.97 | $41.31 | $40.50 | +950.60% |
| September, 2030 | $45.68 | $42.85 | $44.95 | +1,071% |
| October, 2030 | $45.67 | $46.18 | $44.73 | +1,071% |
| November, 2030 | $32.50 | $45.00 | $47.51 | +733.25% |
| December, 2030 | $47.10 | $44.28 | $46.70 | +1,108% |
5.91%
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):